Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0101167 Composition of Organic Compounds
The present invention relates to compositions comprising a construct comprising the A.beta.1-6 peptide and a pharmaceutically acceptable adjuvant, for the...
2016/0101166 COMPOSITIONS AND KITS FOR TREATING PRURITUS AND METHODS OF USING THE SAME
A treatment for pruritus is described that is based upon amylase. The amylases (.alpha.-, .beta.-, .gamma.-amylase) are noted for the cleavage of the...
2016/0101165 COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME
A debridement enzyme for necrotic tissue is described that is not dependent upon proteolytic enzymatic activity but instead utilizes the amylase family of...
2016/0101164 CYCLE ADENOSINE MONOPHOSPHATE-INCOMPETENT ADENYLYL CYCLASE AND COMPOSITIONS AND METHODS FOR TREATING HEART...
The invention provides methods for treating, ameliorating or protecting (preventing) an individual or a patient having or at risk of having heart disease or...
2016/0101163 Stabilised Compositions of Factor VII Polypeptides
The invention relates to chemically as well as physically stable kits and compositions comprising polypeptides, in particular Factor VII or Factor VII-related...
2016/0101162 SINGLE-DOSE ADMINISTRATION OF FACTOR VIIa
The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of a Factor VIIa equivalent. Preferably,...
2016/0101161 ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYE
The present disclosure provides novel compositions and methods for treating an infection of the eye resulting from an infection of a member of the...
2016/0101160 mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
Compositions for modulating the expression of a protein in a target cell comprising at least one RNA molecule which comprises at least one modification 5...
2016/0101159 METHODS AND COMPOSITIONS FOR PROMITING GLUCOSE HOMEOSTASIS
A method of reducing blood glucose in a subject has been developed. In preferred embodiments, the method involves administering to the subject a specific...
2016/0101158 PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME
Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of GLP-1, and/or...
2016/0101157 METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST...
The present invention provides a method for treating multiple sclerosis (MS), and for reducing flu-like symptoms associated with administration of an...
2016/0101156 COMPOSITION CONTAINING PALMULTANG EXTRACT FOR PROMOTING PROLIFERATION OF STEM CELLS DERIVED FROM BONE MARROW
The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and more...
2016/0101155 METHODS OF TREATING NEUROLOGICAL AUTOIMMUNE DISORDERS WITH CYCLOPHOSPHAMIDE
Described herein are methods for treating neurological autoimmune disorders in which the treatment method includes administering an immunoablative agent to...
2016/0101154 PEPTIDE FOR INHIBITION OF BINDING BETWEEN ANGIOPOIETIN-2 AND INTEGRIN AND USE THEREOF
Angiopoietin-2 (Ang2) derived peptides, polypeptides, and peptide complexes, and a method for inhibition of binding between Ang2 and integrin and prevention...
2016/0101153 USE OF LONG-ACTING HUMAN RECOMBINANT SOLUBLE TUMOR NECROSIS FACTOR A RECEPTOR IN THE PREPARATION OF DRUGS FOR...
The proposed invention involves the use of new drugs with the recombinant soluble tumor necrosis .alpha. receptor (HusTNFR) and belongs to the gene engineering...
2016/0101152 USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS
The present invention provides methods for treating angiogenic eye disorders by sequentially administering multiple doses of a VEGF antagonist to a patient....
2016/0101151 COMPOUNDS AND METHODS OF MODULATING ANGIOGENESIS
A pharmaceutical composition includes a synthetic peptide consisting of about 10 to about 50 amino acids and having an amino acid sequence substantially...
2016/0101150 PEPTIDES HAVING ANTI-INFLAMMATORY PROPERTIES
Aspects of the present invention relate to peptides having anti-inflammatory activity, compositions containing one or more of the peptides, and use of the...
2016/0101149 Method for Therapeutic Replenishment and Enrichment of Ocular Surface Lubrication
The present invention provides a pharmaceutical composition, and methods of use thereof, for treating ocular boundary deficiency, symptoms associated...
2016/0101148 TREATMENT AND PREVENTION OF BACTERIAL SKIN INFECTIONS USING ORITAVANCIN
Methods for the treatment and prevention of bacterial skin infections using the glycopeptide antibiotic oritavancin are disclosed.
2016/0101147 FORMULATIONS OF VANCOMYCIN
Vancomycin-containing compositions substantially free of precipitation after at least about 12 months of storage at refrigerated or ambient conditions are...
2016/0101146 TREATMENT FOR INFECTION WITH HEPATITIS B VIRUS ALONE OR IN COMBINATION WITH HEPATITIS DELTA VIRUS AND...
The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis B and Hepatitis D virus infections.
2016/0101145 PEPTIDOMIMETIC MACROCYCLES AND FORMULATIONS THEREOF
Aqueous pharmaceutical formulations, for parenteral administration, comprising peptidomimetic macrocycle or a pharmaceutically acceptable salt thereof wherein...
2016/0101144 COMPOSITION FOR PREVENTING, RELIEVING OR TREATING COLITIS, CONTAINING COMPLEX EXTRACTS
The present invention relates to a novel use of an Anemarrhena asphodeloides Bunge extract, and the like, and a Rhizoma Coptidis extract, and the like, and...
2016/0101143 COMPOSITION FOR PREVENTING OR TREATING HEPATITIS C INCLUDING VITIDIS VINFERAE RADIX EXTRACT OR FRACTION THEREOF...
Provided is a method for preventing or treating hepatitis C by administrating a composition including, as an active ingredient, a Vitidis Vinferae Radix...
2016/0101142 METHOD FOR OBTAINING A PLANT EXTRACT AND ASSOCIATED COMPOSITIONS
The invention relates to a method for obtaining a composition from a plant extract, to assist in the treatment or prevention of disorders or diseases related...
2016/0101141 Topical Treatment of Sports Related Injuries
The present invention relates to a homeopathic composition that may be used as a pain management treatment of musculoskeletal injuries. More particularly, the...
2016/0101140 Method for Processing Rosaceous Kernels
A method for processing rosaceous kernels includes the steps of preparing a predetermined amount of rosaceous kernels, heating the rosaceous kernels to a...
2016/0101139 TOPICAL TREATMENT FOR USE AS A SLEEP AID
The present invention relates to a homeopathic sleep aid composition that may be applied topically. A composition may contain a synergistic blend of snake...
2016/0101138 Medicinal Composition of Amaranth Extract Having Enriched Nitrate Content and a Method of Preparing the same
An extract of Amaranth, having enriched nitrate content, L-arginine, Flavonoids, saponins, alkaloids, carbohydrates, proteins, potassium, and with negligible...
2016/0101137 MICROORGANISM BIOMASS FOR PREVENTION AND REDUCTION OF THE ADVERSE EFFECTS OF PATHOGENS IN DIGESTIVE TRACT
The present invention relates to microorganism biomass and a feed or food composition which can be used in preventing or reducing the adverse effects of...
2016/0101136 PROPHYLACTIC, AMELIORATING OR THERAPEUTIC AGENT FOR ORAL DISEASES
To provide a novel lactic acid bacterium strain having a broad antibacterial spectrum against bacteria that cause oral diseases, from which a fermented product...
2016/0101135 Method and Composition for Hypothermic Storage of Placental Tissue
A tissue storage solution includes hypothermic storage compositions and methods. The hypothermic storage composition includes media containing Dulbecco's...
2016/0101134 KITS AND METHODS FOR PROCESSING STEM CELLS FROM BONE MARROW OR UMBILICAL CORD BLOOD
Provided herein are kits for processing stem cells from bone marrow or umbilical cord blood, comprising: a) a precipitation reagent comprising an aqueous...
2016/0101133 ORGANOIDS COMPRISING ISOLATED RENAL CELLS AND USE THEREOF
Described herein are organoids comprising admixtures of selected bioactive primary renal cells and a bioactive cell population, e.g., an endothelial cell...
2016/0101132 ENHANCED ANABOLIC CYTOKINE PRODUCTION AND DELIVERY SYSTEM
Techniques and devices for removing (filtering out) unwanted/inhibitory components (for example, products, byproducts and/or cell output such as inhibitory...
2016/0101131 TREATMENT OF DISEASES
Provided are methods for the treatment of various neural disorders including non-demyelinating neural disorders, such as Alzheimer's disease, as well as...
2016/0101130 SILVER NANOPLATE COMPOSITIONS AND METHODS
Embodiments of the present invention relate to methods for preparing high optical density solutions of nanoplates, such as silver nanoplates or silver platelet...
2016/0101129 Medicinal Clay Preparation
The present invention relates to a medicinal clay preparation containing 90-99.9% w/w medicinal clay and 0.1-10% w/w binders. It further relates to a method...
2016/0101128 TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS
The invention provides methods of inducing an immune response to cancer comprising co-administering to a cancer patient one or more TLR9 agonists and one or...
2016/0101127 Single Dose Oral Formulations and Methods for Treatment of Cats with Ectoparasiticidal Spinosad
This invention provides a single-dose oral formulation of spinosad for the extended control of a C. felis infestation on a cat at a predictable dose of...
2016/0101126 COMPOSITIONS COMPRISING NANOPARTICLES AND APOPTOTIC AGENTS AND METHODS OF USE
Compositions comprising nanoparticles, such as silver or gold nanoparticles or carbon nanotubes (CNTs), and apoptotic agents are described. The nanoparticles...
2016/0101125 COMPOSITIONS FOR USE IN CARTILAGE BREAKDOWN
The present invention relates to use of a composition comprising rutin for maintenance of joint health or prevention or treatment of joint disorders. In...
2016/0101124 NANO-LIPOSOMAL AMINOGLYCOSIDE-THYMOQUINONE FORMULATIONS
The nano-liposomal aminoglycoside-thymoquinone formulations are suitable for administration to a mammal and include an aminoglycoside antibiotic (amikacin,...
2016/0101123 BETA-MANNOSYLCERAMIDE AND STIMULATION OF NKT CELL ANTI-TUMOR IMMUNITY
.beta.-mannosylceramides or salts or solvates thereof in a pharmaceutically acceptable carrier, for use as a Type I NKT cell agonist in conjunction with a...
2016/0101122 COMPOSITIONS AND METHODS FOR TREATING SPINOCEREBELLAR ATAXIA
The present invention provides alleviating a sign or symptom of spinocerebellar ataxia by administering an injection of an aqueous formulation comprising...
2016/0101121 COMPOSITION COMPRISING XANTHOCERAS SORBIFOLIA EXTRACTS, COMPOUNDS ISOLATED FROM SAME, METHODS FOR PREPARING...
This invention provides compositions, methods and process of producing extracts from Xanthoceras sorbifolia. The extract comprises alkaloids, coumarins,...
2016/0101120 METHOD FOR PRODUCING A MIXTURE OF NEUTRAL OLIGOSACCHARIDES EXTRACTED FROM FLAXSEED
The method for producing a mixture of neutral oligosaccharides extracted from flaxseed includes oligosaccharides having high molar masses generated by...
2016/0101119 Controlled Release Doxycycline
The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline...
2016/0101118 PHARMACEUTICAL COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.